UPDATE: Oppenheimer Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'We See a Breakout Year Ahead'
Tweet Send to a Friend
(Updated - October 31, 2022 6:20 AM EDT)
Oppenheimer analyst Leland Gershell upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
